Sodium selenite inhibits proliferation and metastasis through ROS-mediated NF-κB signaling in renal cell carcinoma

Background: Sodium selenite (SSE) has been reported to exert anti-tumor effects in several Cancer cells. However, the underlying mechanisms in renal Cancer are yet to be elucidated. The effects of SSE on the proliferation, metastasis, and Apoptosis of renal Cancer cells, as well as its mechanism, were investigated in this study.

Methods: ACHN and 786-O renal Cancer cells were treated with different concentrations of SSE, MTT, and colony formation assays were used to detect the proliferation ability of cells. The migration of cells was detected using scratch-wound-healing and transwell-migration assays. The effect of SSE on Apoptosis was assessed by AnnexinV-FITC/PI double staining. Besides, Western blotting was employed to detect the protein-expression level and elucidate the underlying pathways. We also made subcutaneous xenografts in athymic mice to verify the effect of SSE on tumor growth in vivo.

Results: Our results demonstrated that treatment with SSE resulted in significant inhibition of cell proliferation and migration. Flow cytometry and Western blot confirmed that SSE induced Apoptosis via the endogenous apoptotic pathway. We also confirmed that SSE treatment causes an increase in intracellular Reactive Oxygen Species (ROS) levels, resulting in the inhibition of nuclear transcription factor-κB (NF-κB) signaling. Modulation of the ROS level by the chemical inhibitor N-acetyl-cysteine reversed the effect of SSE on cells. Similarly, subcutaneous xenografts in athymic mice models showed that SSE inhibits tumor growth in vivo.

Conclusion: These results indicate that SSE inhibits proliferation and migration and induces Apoptosis via ROS mediated inhibition of NF-κB signaling in renal Cancer cells.